Our results showing that G-CSF can promote inflammatory profiles and cardiac thrombosis that leads to cardiac dysfunction, are in contrast to previous reports showing G-CSF therapy to be beneficial in acute myocardial infarction [3,4,31,32] and chronic cardiomyopathy induced by doxorubicin toxicity [33]. Here, CSF3 is linked to myocardial infarction.